RxDoctor Payments DataLook up a doctor →

David Dibardino, MD

Critical Care Medicine · Philadelphia, PANPI 1003127135

Payments from drug & device makers

$2,090,639in general payments, 2019–2025

Across 193 payments — averaging $10,832 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$1.1M
  • Galvanize Therapeutics, Inc$612K
  • Johnson & Johnson$139K
  • Ethicon Endo-surgery Inc.$101K
  • Erbe Elektromedizin GmbH$99K
  • Siemens Medical Solutions USA, Inc.$19K
  • plus $43K from 13 others

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,090,639 in reported general payments places this provider in the 95th percentile of 354 critical care medicine providers in Pennsylvania.

See all critical care medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$84,901
Medicare patients
267
Services billed
891

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →